After years of innovation, immunotherapy has radically changed therapeutic dogma for patients. Ranging from antibody therapies to immuno-oncology, it entails various approaches and technics which are sometimes not easy to capture. Hence, this conference aims at bringing various stakehodlers from industry and academics, corporate and start-up, to exchange about most recent trends and practices in immunotherapy. 

PRE-CONFERENCE SESSION

09:00 – 09:30 am :     Welcoming participants

09:30 – 10:30 am :     Workshop

                                   Anne HEPBURN, Med. Writing & Reg. Affairs Dir. 
                                   4Clinics, Brussels
                                   Immunological clinical endpoints : How to choose ?

10:30 – 12:30 am :     Lightcast Accelerator Start-up Session 

                                   Nicolas ANDRE, BETTERTHIS

                                   Lucile ASTORGUES-XERRI, EARLY DRUG DISCOVERY GROUP

                                   Arnaud MEIMOUN, CRESCENTIA CONSULTING

                                   Bruno THILLIER, SYNTHELIS

  FREE LUNCH BREAK 

MAIN CONFERENCE SESSION

1:30 – 2:30 pm :         Speed Networking Session 

2:30 – 3:00 pm :         Coffee Break

3:00 – 3:30 pm :         A word from E-JASA and its sponsors

3:30 – 5:00 pm :         Conference Cycle

                                   Pr. Nabila SEDDIKI, Associate Professor & Chair of Excellence
                                   INSERM-IRMB Pathology and Immunotherapy against HIV infection
                                  Regulatory lymphocytes in health and disease:
                                 How can we deal with their dual role in HIV immunotherapy ?

                                   Dr. Abderrahim LACHGAR, COO
                                   INVECTYS
                                   Clinical development in Immunotherapy :
                                   The case of Therapeutic Cancer Vaccines

                                   Dr. Dominique BLANCHARD, Immunogy Specialist
                                   Senior Consultant (Cellectis, Medicene, Genentech, ...)
                                   Immunotherapy : The end of Cancer ?

5:00 – 5:30 pm :         Panel and Conference Closing

5:30 - 7:00 pm :         Drinks & Open Networking

This event has received support from